Gut Microbiota and Diarrhea in Breast Cancer Patients Receiving Pyrotinib

Clinical trial NCT07264985 · RECRUITING

Trial details

NCT number: NCT07264985
Sponsor: Hubei Cancer Hospital
Status: RECRUITING
Study type: OBSERVATIONAL

Breast Cancer Drug-Related Side Effects Diarrhea

Start date: 2025-12-25
Primary completion: 2027-06-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.